Related Experiment Video
Updated: Jun 9, 2026

08:54
Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples
Published on: May 19, 2020
Development and validation of a short-form Tuberculosis Medication Adherence Scale (TBMAS-SF).
Wei Zang1, Xiaoxin Zhang2, Wenjing Gu3
1Pharmacy Department, Infectious Disease Hospital of Heilongjiang Province, Harbin, China.
Journal of Health, Population, and Nutrition
|June 7, 2026
Summary
A new Tuberculosis Medication Adherence Scale (TBMAS-SF) offers a shorter, efficient tool for tuberculosis patients. It shows acceptable reliability and validity, though further validation is recommended.
Area of Science:
- Medical Research
- Psychometrics
- Public Health
Background:
- Developing efficient measurement tools is crucial for managing tuberculosis.
- The original Tuberculosis Medication Adherence Scale (TBMAS) has been abbreviated to create a more concise version.
- Classical Test Theory (CTT) principles guided the development and validation process.
Purpose of the Study:
- To develop and validate a concise, abbreviated Tuberculosis Medication Adherence Scale (TBMAS-SF).
- To provide a more efficient measurement tool for tuberculosis patients.
- To ensure the shortened scale maintains acceptable psychometric properties.
Main Methods:
- A survey was conducted with tuberculosis patients at the Heilongjiang Provincial Institute of Infectious Disease Control and Prevention.
- Convenient sampling and the TBMAS were used for data collection.
- Data were analyzed using SPSS 26.0 and Amos 24.0, with 404 valid responses from 496 distributed questionnaires (81.45% response rate).
Main Results:
- The TBMAS-SF demonstrated acceptable reliability (Cronbach's α = 0.931, split-half = 0.739).
- Confirmatory factor analysis indicated acceptable comparative fit but suboptimal absolute fit indices.
- A modest positive correlation was found between TBMAS-SF scores and medication literacy (r=0.228, p<0.01), suggesting acceptable empirical validity.
Conclusions:
- The TBMAS-SF exhibits acceptable internal consistency and promising construct validity.
- Suboptimal absolute fit indices suggest that further refinement and cross-validation are necessary.
- The abbreviated scale offers a potentially more efficient tool for assessing medication adherence in tuberculosis patients.
Related Concept Videos
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
